First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent
Condition:   Healthy Interventions:   Drug: RVP-001;   Drug: Placebo Sponsors:   Reveal Pharmaceuticals Inc.;   National Cancer Institute (NCI);   Quotient Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2022 Category: Research Source Type: clinical trials

An Open-label, Phase I/II Study of Manganese Plus Radiotherapy in Patients With Metastatic Solid Tumors or Lymphoma
Conditions:   Solid Tumor;   Lymphoma Interventions:   Drug: Manganese Chloride;   Radiation: Radiotherapy;   Drug: Chemo-immunotherapy Sponsor:   Chinese PLA General Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 5, 2021 Category: Research Source Type: clinical trials